Form 4: GeneDx CFO Sells Shares for Tax Obligations

GeneDx Holdings Corp.'s CFO, Kevin Feeley, sold shares to cover tax withholding obligations related to vested restricted stock units.

Summary

• GeneDx Holdings Corp. Chief Financial Officer, Kevin Feeley, reported transactions on December 1, 2025.
• Feeley acquired 717 shares of Class A Common Stock upon the settlement of Restricted Stock Units (RSUs) for no consideration.
• He subsequently sold 377 shares of Class A Common Stock at a weighted average price of $162.536 per share.
• The sale was explicitly stated as a 'sell to cover' transaction to satisfy tax withholding obligations related to the RSU vesting and was not a discretionary sale.
• Following these reported transactions, Feeley directly beneficially owns 4,193 shares of Class A Common Stock.
• The reported total of 4,570 shares before the sale included 96 shares acquired through the Issuer's Employee Stock Purchase Plan.
• In addition to the directly owned shares, Feeley beneficially owns RSUs representing contingent rights to receive up to an aggregate of 123,163 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which vest according to their respective terms.
• The RSUs vest quarterly, with 6.25% of the total award vesting per quarter, subject to continued service, and the first tranche vested on December 1, 2022.

Sentiment

Score: 5

Explanation: The filing reports a routine 'sell to cover' transaction by a company officer to satisfy tax obligations upon RSU vesting, which is a common and expected event and does not reflect a discretionary investment decision. Therefore, the sentiment is neutral.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the fulfillment of compensation agreements and continued service by a key executive.
• The acquisition of 96 shares through the Employee Stock Purchase Plan demonstrates ongoing employee investment in the company.

Negatives

• The sale of 377 shares, even for tax purposes, results in a reduction of the CFO's direct beneficial ownership of Class A Common Stock.

Management Comments

• "The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."
• "The sale was to satisfy tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person."

Industry Context

This filing details a routine insider transaction, specifically a 'sell to cover' event, which is a common practice for executives receiving equity compensation. It does not provide information related to broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The sale of shares for tax purposes is a non-discretionary event and is unlikely to have a significant impact on the company's share price or long-term value.
• Employees: The vesting of RSUs and participation in the Employee Stock Purchase Plan are part of standard employee compensation and benefits, indicating ongoing incentives for key personnel.

Next Steps

• Continued vesting of remaining Restricted Stock Units and options according to their respective terms, subject to the Reporting Person's continued service to the Issuer.

Key Dates

Recommendation

This Form 4 details a routine 'sell to cover' transaction by the CFO to satisfy tax obligations upon the vesting of restricted stock units. Such transactions are common and do not typically signal a change in the company's fundamentals or the officer's long-term view of the stock. The filing provides no new information that would warrant a change in investment recommendation, thus a 'hold' recommendation is appropriate.

Keywords

GeneDx Holdings Corp, WGS, Form 4, insider transaction, CFO, Kevin Feeley, restricted stock units, RSU, stock sale, tax withholding, employee stock purchase plan